**To the Editor:** Rickettsiosis due to *Rickettsia felis* is an emerging disease that has been reported worldwide ([@R1]). Fever, headache, myalgia, and macular rash have been attributed to *R. felis* infection in humans ([@R1]). In South America, *R. felis* infection in fleas (mostly *Ctenocephalides* spp.) has been reported only in Brazil, Peru, and Uruguay ([@R2]*--*[@R3]). Although a growing number of articles have reported that *R. felis* is transmitted by fleas, the acquisition mechanism of *R. felis* by vertebrates or uninfected fleas in nature remains unknown ([@R4]).

Cats experimentally exposed to *R. felis--*infected fleas have been shown to become seropositive ([@R5]). However, neither serologic nor molecular evidence of *R. felis* infection has been reported in cats under natural conditions, despite the fact that most *C. felis* fleas are infected by *R. felis* ([@R6]*,*[@R7]).

In November 2006, we investigated the presence of rickettsial DNA in 30 *C. felis* fleas randomly collected from 22 domestic cats privately owned and housed indoors in a single household in Santiago, Chile. To detect rickettsial DNA in each individual flea, PCRs were performed that targeted a 398-nt fragment of the rickettsial *gltA* gene and an 856-nt fragment of the rickettsial *ompB* gene ([@R7]*,*[@R8]).

A total of 21 individual fleas (70%) yielded expected PCR products for both *gltA* and *ompB* genes. PCR *gltA* products from the 21 fleas and *ompB* products from 5 fleas were subjected to DNA sequencing as described ([@R7]). The *gltA* partial sequences obtained from 21 fleas were identical, as were the *ompB* partial sequences from 5 fleas. These sequences were 100% identical to corresponding sequences in the *R. felis* genome (GenBank accession no. CP000053).

Blood serum samples were collected from the 22 cats and tested by indirect immunofluorescence assay (IFA) with crude antigens derived from 6 *Rickettsia* isolates from Brazil: *R. bellii*, *R. amblyommii*, *R. rhipicephali*, *R. rickettsii*, *R. parkeri*, and *R. felis* ([@R7],[@R9]). Serum was considered to contain antibodies against rickettsiae if it displayed a reaction at 1:64 dilution. End-point titers against each *Rickettsia* species were determined by testing serial 2-fold serum dilutions. Reactive serum specimens were tested in 2 or 3 replications by 2 readers before the end-point titer was determined. Serum showing a *Rickettsia* species titer at least 4-fold higher than those observed for the other *Ricketttsia* species was considered homologous to the first *Rickettsia* species or to a very closely related genotype ([@R7]*,*[@R9]). In each slide, a nonreactive cat serum specimen (negative control) and a known reactive cat serum specimen (positive control) were tested at the 1:64 dilution ([@R7]).

IFA detected antibodies reactive with *R. felis* (titer [\>]{.ul}64) in 16 (72.7%) of 22 cats. Among those, 5 (22.7%) also reacted with *R. rhipicephali*, 4 (18.2%) with *R. bellii,* 3 (13.6%) with *R. parkeri,* 2 (9.1%) with *R. rickettsii,* and 1 (4.5%) with *R*. *amblyommii.* No serum reacted with any other *Rickettsia* species without reacting with *R. felis* ([Table](#T1){ref-type="table"}). Four cat serum specimens (cats 1, 3, 8, and 11) showed titers to *R. felis* at least 4-fold higher than those to any of the other 5 antigens. The antibody titers in these 4 animals were considered to have been stimulated by *R. felis* infection. For the remaining 12 seropositive cats, we could not discern whether *R. felis* had been the infection agent because the results displayed a single titer of 64 for *R. felis* or showed similar titers for other *Rickettsia* species.

###### End-point titers of indirect immunofluorescence assay (IFA) for 6 *Rickettsia* species in cats from a household in Santiago, Chile\*

  Cat no.   IFA titers for *Rickettsia* antigens   PAIHR                           
  --------- -------------------------------------- ------- ----- ----- ----- ----- ------------
  1         128                                    --      --    --    --    --    *R. felis*
  2         256                                    256     128   --    --    --    
  3         512                                    128     64    --    --    --    *R. felis*
  5         64                                     --      --    --    --    --    
  6         64                                     64      --    --    --    --    
  7         64                                     --      --    --    --    --    
  8         128                                    --      --    --    --    --    *R. felis*
  9         64                                     --      --    --    --    --    
  10        64                                     --      --    --    --    --    
  11        128                                    --      --    --    --    --    *R. felis*
  12        64                                     --      --    --    --    --    
  14        128                                    --      64    128   --    128   
  15        64                                     --      --    --    --    --    
  19        64                                     --      --    --    --    --    
  21        128                                    64      128   128   128   --    
  22        64                                     64      --    64    64    --    

\*PAIHR, possible antigen involved in a homologous reaction (serum showing for a *Rickettsia* species titer at least 4-fold higher than that observed for any other *Ricketttsia* species was considered homologous to the first *Rickettsia* species); --, nonreactive at titer [\>]{.ul}64.

We report 70% *R. felis*--infected fleas in this study on the basis of the concordant results of 2 PCR amplifications (*gltA* and *ompB*) and DNA sequencing. This infection rate is within the range (13.5%--90%) that has been reported for *R. felis* infecting *Ctenocephalides* fleas in Brazil and Uruguay ([@R2]*,*[@R3]*,*[@R7]). Sixteen (72.7%) cats contained *R. felis--*reactive antibodies; 4 of them showed titers to *R. felis* at least 4-fold higher than those to the other 5 rickettsial strains, findings that enabled us to technically conclude that these cats were exposed to *R. felis* or a closely related organism ([@R1]*,*[@R7]*,*[@R9]). Our finding of 70% *R. felis* infection in fleas infesting the cats indicates that cats acquired the infection through infected fleas. However, the mechanism of *R. felis* transmission by fleas is yet to be demonstrated under experimental conditions.

To our knowledge, the presence of *R. felis*, or a spotted fever group *Rickettsia* species, has not been reported in Chile. Recent investigations have provided clinical and serologic evidence of canine ([@R10]) and human (K. Abarca and J. Lopez, unpub. data) infection by spotted fever rickettsia in Chile, confirmed by IFA that used *R. conorii* commercial antigen. Since substantial serologic cross-reaction occurs between *R. conorii* and *R. felis* antigens ([@R1]), *R. felis* could be causing infection in dogs or humans in Chile.
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